<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Spectral Presaturation Inversion Recovery MR Imaging Sequence after Gadolinium Injection to Differentiate Fibrotic Scar Tissue and Neoplastic Strands in the Mesorectal Fat in Patients Undergoing Restaging of Rectal Carcinoma after Neoadjuvant Chemo- and Radiation Therapy" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/spectral-presaturation-inversion-recovery-mr-imaging-sequence-after-gadolinium-injection-to-differen/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/spectral-presaturation-inversion-recovery-mr-imaging-sequence-after-gadolinium-injection-to-differen/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2011-10-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Spectral Presaturation Inversion Recovery MR Imaging Sequence after Gadolinium Injection to Differentiate Fibrotic Scar Tissue and Neoplastic Strands in the Mesorectal Fat in Patients Undergoing Restaging of Rectal Carcinoma after Neoadjuvant Chemo- and Radiation Therapy" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2011-10-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Spectral Presaturation Inversion Recovery MR Imaging Sequence after Gadolinium Injection to Differentiate Fibrotic Scar Tissue and Neoplastic Strands in the Mesorectal Fat in Patients Undergoing Restaging of Rectal Carcinoma after Neoadjuvant Chemo- and Radiation Therapy","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/spectral-presaturation-inversion-recovery-mr-imaging-sequence-after-gadolinium-injection-to-differen/"},"url":"https://clinicaltree.github.io/posts/spectral-presaturation-inversion-recovery-mr-imaging-sequence-after-gadolinium-injection-to-differen/"}</script><title>Spectral Presaturation Inversion Recovery MR Imaging Sequence after Gadolinium Injection to Differentiate Fibrotic Scar Tissue and Neoplastic Strands in the Mesorectal Fat in Patients Undergoing Restaging of Rectal Carcinoma after Neoadjuvant Chemo- and Radiation Therapy | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Spectral Presaturation Inversion Recovery MR Imaging Sequence after Gadolinium Injection to Differentiate Fibrotic Scar Tissue and Neoplastic Strands in the Mesorectal Fat in Patients Undergoing Restaging of Rectal Carcinoma after Neoadjuvant Chemo- and Radiation Therapy</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Spectral Presaturation Inversion Recovery MR Imaging Sequence after Gadolinium Injection to Differentiate Fibrotic Scar Tissue and Neoplastic Strands in the Mesorectal Fat in Patients Undergoing Restaging of Rectal Carcinoma after Neoadjuvant Chemo- and Radiation Therapy</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1320080400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Oct 31, 2011 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Emilio Quaia MD</a> </em>, <em> <a href="">Veronica Ulcigrai MD</a> </em>, <em> <a href="">Matteo Coss MD</a> </em>, <em> <a href="">Luca De Paoli MD</a> </em>, <em> <a href="">Maja Ukmar MD</a> </em>, <em> <a href="">Fabrizio Zanconati MD</a> </em>, <em> <a href="">Alessro De Pellegrin MD</a> </em>, <em> <a href="">Nicolò De Manzini MD</a> </em>, <em> <a href="">Maria Assunta Cova MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2590 words"> <em>14 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To retrospectively assess the value of spectral presaturation by inversion-recovery (SPIR) magnetic resonance (MR) imaging sequence after gadolinium injection to differentiate fibrotic scar tissue and tumoral infiltration within the mesorectal fat in patients with rectal carcinoma undergoing MR restaging after neoadjuvant chemo- and radiation therapy (CRT).</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Forty-three consecutive patients (mean age, 65.8 years; range, 46–85 years; male:female, 29:14) with locally advanced rectal carcinoma underwent CRT followed by surgery. MR imaging was performed before and after completion of CRT by using T2-weighted turbo spin-echo and T1-weighted SPIR sequences before and after gadolinium injection, and MR images were assessed by two radiologists in consensus. Logistic regression was conducted to test the significance of the MR image findings with histology.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>After CRT the disease was either limited to the rectal wall ( <em>n</em> = 18 patients) or presented perirectal infiltration ( <em>n</em> = 25) on histology. In 21 patients, mesorectal enhancing strands were observed. Reticular-shaped enhancing strands reaching the mesorectal fascia presented the highest correlation with tumor infiltration of the mesorectal fat (OR 130.33, 95% CI: 4.1–4220.29; logistic regression), whereas linear-shaped enhancing strands either reaching or not reaching the mesorectal fascia (OR 0.25 or 0.1, 95% CI: 0.024–2.6 or 0.01–1.07) revealed the lowest correlation.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Reticular-shaped enhancing strands on SPIR MR imaging after gadolinium injection are associated with tumor infiltration of the mesorectal fat.</p><p>Total mesorectal excision is widely accepted as standard surgical practice for rectal cancer , and it provides the best chance of a tumor-free circumferential resection margin . Local recurrence is directly related to incomplete resection of the tumor and the most important parameter related to local recurrence is the distance between the tumor and the mesorectal fascia . Locally advanced rectal cancer with extramural spread (T3 tumor) has high frequency of local recurrence and metastasis. Nowadays, the standard treatment for locally advanced rectal cancer consists of preoperative neoadjuvant concomitant radiation and chemotherapy (CRT) followed by standard resection of the rectum and resection of the surrounding organs .</p><p>The classic approach of defining the T stage of the tumor is based on magnetic resonance (MR) imaging or endoscopic ultrasound and may lead to staging failures in the differentiation of T2 and borderline T3 tumors . The measurement of tumor extent relative to the mesorectal fascia and the prediction of tumor-free resection margins on the basis of MR imaging may be more feasible than defining the T stage . MR imaging has an accuracy of 66% in predicting resection margin involvement during restaging of irradiated rectal cancers (sensitivity, 100%; specificity, 35%; positive predictive value, 58%; negative predictive value, 100%) . The reported overall accuracy of MR imaging in predicting the pathologic stage of nonirradiated rectal cancer is 71%–91% (mean, 85%) for T staging, and 43%–85% (75%) for N staging . However, the reported overall accuracy of MR imaging in the restaging of irradiated rectal cancer is much lower being 47%–54% (50%) for T staging and 64%–68% (65%) for N staging , and it is even worse for mucin-producing tumors.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="patients"><span class="mr-2">Patients</span><a href="#patients" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="neoadjuvant-treatment"><span class="mr-2">Neoadjuvant Treatment</span><a href="#neoadjuvant-treatment" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mr-imaging"><span class="mr-2">MR Imaging</span><a href="#mr-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="consensual-analysis"><span class="mr-2">Consensual Analysis</span><a href="#consensual-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>T Stage Before and After Neoadjuvant Therapy</p><p>Tumor Before CRT ∗ After CRT † T0/T2 0 18 ‡ T3 38 23 T4 5 2</p><p>Note:–Neoadjuvant treatment refers to radiation therapy with concomitant chemotherapy.</p><p>CRT, neoadjuvant chemo- and radiation therapy.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/0_1s20S1076633211003576.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/0_1s20S1076633211003576.jpg" alt="Figure 1, Scheme. The different patterns of enhancing strands in the mesorectal fat. (a) Rectal cancer is represented as thickening of the visceral wall without any sign of mesorectal fat infiltration. (b) Rectal cancer with reticular-shaped enhancing strands in the adjacent mesorectal fat. (c) Rectal cancer with linear-shaped enhancing strands in the mesorectal fat. (d) Rectal cancer with reticular or linear-shaped enhancing strands and nodules. b, bladder; r, rectum; mf, mesorectal fat; s, sacral bone." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="surgery-and-histopathologic-evaluation"><span class="mr-2">Surgery and Histopathologic Evaluation</span><a href="#surgery-and-histopathologic-evaluation" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Patient-by-Patient MR Imaging Findings</p><p>Patient Number Sex Age (y) T/N Stage ∗ Enhancing Nodules Reticular Enhancing Strands Linear-shaped Enhancing Strands Mesorectal Fat Infiltration on Histology 1 M 60 T3/N0 − − − + 2 M 74 T2/N1 − − − − 3 F 71 T2/N0 − − + − 4 M 70 T3/N2 − + − + 5 M 71 T2/N0 − − + − 6 F 64 T3/N0 − − − + 7 M 62 T2/N0 − − + − 8 F 78 T2/N0 − − + − 9 M 64 T3/N1 − − − + 10 M 60 T3/N2 + + − + 11 M 68 T3/N1 − + − + 12 F 60 T3/N0 − + − + 13 M 72 T1/N0 − + − − 14 F 77 T1/N0 − − − − 15 F 56 T3/N0 − − − + 16 M 78 T3/N1 − + − + 17 M 66 T3/N0 − − − + 18 F 80 T3/N2 − − − + 19 F 52 T3/N1 − + − + 20 M 69 T2/N1 − − − − 21 M 63 T3/N1 − − − + 22 M 74 T3/N0 − − + + 23 M 56 T0/N0 − − − − 24 M 85 T3/N2 − + − + 25 M 73 T2/N1 − − − − 26 M 52 T1/N0 + − + − 27 M 60 T4/N1 − + − + 28 M 68 T3/N1 − − − + 29 F 67 T1/N0 − − + − 30 F 61 T3/N0 − − − + 31 M 60 T2/N0 + + − − 32 F 46 T2/N0 − − − − 33 M 56 T3/N0 − + − + 34 M 63 T4/N1 − − − + 35 F 63 T3/N0 − − − + 36 M 65 T2/N0 − − − − 37 F 65 T3/N0 − + − + 38 M 60 T3/N0 − + − + 39 M 79 T3/N0 − − − + 40 M 74 T2/N0 − − − − 41 M 60 T2/N0 − − − − 42 M 74 T3/N0 − − + + 43 F 71 T2/N0 − − − −</p><p>Note:–Correlation of MR imaging features and presence of mesorectal fat infiltration after neoadjuvant chemo- and radiation therapy. +, present; −, absent; F, female; M, male; MR, magnetic resonance.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/1_1s20S1076633211003576.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/1_1s20S1076633211003576.jpg" alt="Figure 2, A 55-year-old woman with a rectal cancer. (a,b) Magnetic resonance (MR) imaging before radiation therapy with concomitant chemotherapy. (a) Turbo spin-echo T2-weighted sequence (repetition time [TR]/echo time [TE], 4947/130) and (b) spectral presaturation by inversion recovery T1-weighted sequence (TR/TE, 598/27) after gadolinium injection. Transverse plane. Rectal cancer of the left wall ( large arrow ) without evidence of mesorectal strands. (c,d) MR imaging after radiation therapy with concomitant chemotherapy. (c) Turbo spin-echo T2-weighted sequence (TR/TE, 4947/130) and (d) spectral presaturation by inversion recovery T1-weighted sequence (TR/TE, 598/27) after gadolinium injection. Transverse plane. There is a clear reduction of the tumor volume after neoadjuvant chemo- and radiation therapy with evidence of reticular enhancing strands within the mesorectal fat ( small arrows )." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/2_1s20S1076633211003576.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/2_1s20S1076633211003576.jpg" alt="Figure 3, A 60-year-old woman with a rectal cancer treated by radiation therapy with concomitant chemotherapy. Tumor infiltration of the perirectal fat. (a,b) Turbo spin-echo T2 weighted sequence (repetition time [TR]/echo time [TE], 4947/130) and (c,d) spectral presaturation by inversion recovery T1-weighted sequence (TR/TE, 598/27) after gadolinium injection. Transverse plane. Reticular enhancing strands ( arrows ) within the mesorectal fat. (e) The corresponding transversely sliced pathologic specimen shows residual tumor in the rectal wall ( large black arrow ) and perirectal strands extending into the perirectal fat as ( small black arrows ). (f,g) Histologic evaluation showed perirectal fibrotic strands extending within the mesorectal fat with evidence of tumoral infiltration ( small black arrows ). Hematoxylin-eosin stain; original magnification, ×35. L: rectal lumen." class="lazyload" data-proofer-ignore></a></p><p>Table 3</p><p>Univariate Logistic Regression Analysis</p><p>MR Imaging Findings Odds Ratio (95% CI)<em>P</em> Enhancing nodules .295 (.024–3.58) &gt; .05 Enhancing strands 1.33 (.4–4.43) &gt; .05 Reticular enhancing strands reaching the mesorectal fascia 5.95 (1.09–32.57)</p><p>28.52 (1.34–604.1) &lt; .05</p><p>&lt; .05 Separate enhancing strands reaching the mesorectal fascia .08 (.009–.76)</p><p>.18 0 (.019–1.78) &gt; .05</p><p>&gt; .05</p><p>Note:–Odds ratio according to the different MR imaging parameters.</p><p>Enhancing nodules or strands were defined as focal or linear enhancing areas appearing more intense than the surrounding mesorectal fat.</p><p>CI, confidence intervals; MR, magnetic resonance.</p><p>Table 4</p><p>Multivariate Logistic Regression Analysis</p><p>MR Imaging Findings Odds Ratio (95% CI)<em>P</em> Enhancing nodules .095 (.003–2.87) &gt; .05 Enhancing strands .16 (.017–1.58) &gt; .05 Reticular enhancing strands reaching the mesorectal fascia 62.14 (3.34–1154.26)</p><p>130.33 (4.1–4220.29) &lt; .05</p><p>&lt; .05 Separate enhancing strands reaching the mesorectal fascia .1 (.01–1.07)</p><p>.25 (.024–2.6) &gt; .05</p><p>&gt; .05</p><p>Note:–Odds ratio according to the different MR imaging parameters.</p><p>Enhancing nodules or strands were defined as focal or linear enhancing areas appearing more intense than the surrounding mesorectal fat.</p><p>CI, confidence intervals; MR, magnetic resonance.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/3_1s20S1076633211003576.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/3_1s20S1076633211003576.jpg" alt="Figure 4, A 55-year-old woman with a rectal cancer treated by radiation therapy with concomitant chemotherapy. Fibrotic reaction of the perirectal fat after neoadjuvant radiochemotherapy. (a) Turbo spin-echo T2-weighted sequence (repetition time [TR]/echo time [TE], 4947/130) and (b) spectral presaturation by inversion recovery T1-weighted sequence (TR/TE, 598/27) after gadolinium injection. Transverse plane. Linear-shaped enhancing strands ( arrows ) traveling separately within the mesorectal fat. (c) Histologic evaluation showed fibrotic strands ( arrows ) extending within the mesorectal fat without evidence of tumoral infiltration. Hematoxylin-eosin stain; original magnification, ×35. L: rectal lumen. There is reactive hypertrophy of the muscular layer of the rectal wall." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/4_1s20S1076633211003576.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/SpectralPresaturationInversionRecoveryMRImagingSequenceafterGadoliniumInjectiontoDifferentiateFibroticScarTissueandNeoplasticStrandsintheMesorectalFatinPatientsUndergoingRestagingofRectalCarcinomaafterNeoadjuvantChemoandRadiationTherapy/4_1s20S1076633211003576.jpg" alt="Figure 5, A 60-year-old man with a rectal cancer. (a-d) Magnetic resonance imaging examination after radiation therapy with concomitant chemotherapy. (a,b) Turbo spin-echo T2 weighted sequence (repetition time [TR]/echo time [TE], 4947/130) and (c,d) spectral presaturation by inversion recovery T1-weighted sequence (TR/TE, 598/27) after gadolinium injection. Transverse plane. Reticular enhancing strands ( black arrows ) within the mesorectal fat associated with concomitant enhancing nodules ( white arrows ) projecting from the rectal wall toward the mesorectal fat. (e) Histologic evaluation showed perirectal fibrotic strands extending within the mesorectal fat with tumoral infiltration ( black arrows ). Hematoxylin-eosin stain; original magnification, ×35. There is reactive hypertrophy of the muscular layer of the rectal wall." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Jemal A., Siegel R., Ward E., et. al.: Cancer statistics 2007. CA Cancer J Clin 2007; 57: pp. 43-66.</p><li><p>2. Nagtegaal I.D., Gosens M.: Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer. J Clin Oncol 2007; 25: pp. 1647-1650.</p><li><p>3. Adam I.J., Mohamed M.O., Martin I.G., et. al.: Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344: pp. 707-711.</p><li><p>4. Quirke P., Durdey P., Dixon M.F., et. al.: Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumor spread and surgical excision. Lancet 1986; 2: pp. 996-999.</p><li><p>5. Heald R.J., Ryall R.D.H.: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: pp. 1479-1482.</p><li><p>6. Reynolds J.V., Joyce W.P., Dolan J., et. al.: Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg 1996; 83: pp. 1112-1115.</p><li><p>7. Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D., et. al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: pp. 638-646.</p><li><p>8. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: pp. 980-987.</p><li><p>9. Allen S.D., Padhani A.R., Dzik-Jurasz A.S., et. al.: Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol 2007; 188: pp. 442-451.</p><li><p>10. Beets-Tan R.G., Beets G.L.: Rectal cancer: review with emphasis on MR imaging. Radiology 2004; 232: pp. 335-346.</p><li><p>11. Beets-Tan R.G., Beets G.L., Vliegen R.F., et. al.: Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery. Lancet 2001; 357: pp. 497-504.</p><li><p>12. Vliegen R.F., Beets G.L., Lammering G., et. al.: Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 2008; 246: pp. 454-462.</p><li><p>13. Kuo L.J., Chern M.C., Tsou M.H., et. al.: Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005; 48: pp. 23-28.</p><li><p>14. Chen C.C., Lee R.C., Lin J.K., et. al.: How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?. Dis Colon Rectum 2005; 48: pp. 722-728.</p><li><p>15. Reerink O., Verschueren R.C., Szabo B.G., et. al.: A favourable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis. Eur J Cancer 2003; 39: pp. 192-195.</p><li><p>16. Dresen R.C., Beets G.L., Rutten H.J., et. al.: Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?. Radiology 2009; 252: pp. 71-80.</p><li><p>17. World Medical Association : World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Bull World Health Organ 2001; 79: pp. 373-374.</p><li><p>18. Bipat S., Glas A.S., Slors F.J., et. al.: Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging. Radiology 2004; 232: pp. 773-783.</p><li><p>19. Barbaro B., Vitale R., Leccisotti L., et. al.: Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 2010; 30: pp. 699-721.</p><li><p>20. Wood D.A.: Clinical staging and end results classification: TNM system of clinical classification as applicable to carcinoma of the colon and rectum. Cancer 1971; 28: pp. 109-114.</p><li><p>21. Gareen I.F., Gatsonis C.: Primer on multiple regression models for diagnostic imaging research. Radiology 2003; 229: pp. 305-310.</p><li><p>22. Campbell M.J., Machin D.: Medical statistics, a commonsense approach.1999.WileyChichester, UK 133–134</p><li><p>23. Sistrom C.L., Garvan C.W.: Proportions, odds, and risk. Radiology 2004; 230: pp. 12-19.</p><li><p>24. Cawthorn S.J., Parums D.V., Gibbs N.M., et. al.: Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990; 335: pp. 1055-1059.</p><li><p>25. Willett C.G., Badizadegan K., Ancukiewicz M., et. al.: Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy?. Dis Colon Rectum 1999; 42: pp. 167-173.</p><li><p>26. Harrison J.C., Dean P.J., el-Zeky F., et. al.: From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol 1994; 25: pp. 498-505.</p><li><p>27. Sauer R., Becker H., Hohenberger W., et. al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: pp. 1731-1740.</p><li><p>28. Brown C.L., Ternent C.A., Thorson A.G., et. al.: Response to preoperative chemoradiation in stage II and III rectal cancer. Dis Colon Rectum 2003; 46: pp. 1189-1193.</p><li><p>29. Glimelius B., Grönberg H., Järhult J., et. al.: A systemic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003; 42: pp. 476-492.</p><li><p>30. Glimelius B., Holm T., Blomquist L.: Chemotherapy in addition to preoperative radiotherapy in locally advanced rectal cancer: a systematic overview. Rev Recent Clin Trials 2008; 3: pp. 204-211.</p><li><p>31. Barbaro B., Fiorucci C., Tebala C., et. al.: Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009; 250: pp. 730-739.</p><li><p>32. Dworak O., Keilholz L., Hoffmann A.: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: pp. 19-23.</p><li><p>33. Torkzad M.R., Lindholm J., Martling A., et. al.: MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry. Eur Radiol 2007; 17: pp. 1566-1573.</p><li><p>34. Kim D.J., Kim J.H., Lim J.S., et. al.: Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. Radiographics 2010; 30: pp. 503-516.</p><li><p>35. Vliegen R.F., Beets G.L., von Meyenfeldt M.F., et. al.: Rectal cancer: MR imaging in local staging–is gadolinium–based contrast material helpful?. Radiology 2005; 234: pp. 179-188.</p><li><p>36. Hawnaur J.M., Zhu X.P., Hutchinson C.E.: Quantitative dynamic contrast-enhanced MRI of recurrent pelvic masses in patients treated for cancer. Br J Radiol 1998; 71: pp. 1136-1142.</p><li><p>37. Dicle O., Obuz F., Çakmakci H.: Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 1999; 72: pp. 1155-1159.</p><li><p>38. Rudisch A., Kremser C., Judmaier W., et. al.: Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue. Eur J Radiol 2005; 53: pp. 514-519.</p><li><p>39. Atkin G., Taylor N.J., Daley F.M., et. al.: Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis. Br J Surg 2006; 93: pp. 992-1000.</p><li><p>40. Dinter D.J., Horisberger K., Zechmann C., et. al.: Can dynamic MR imaging predict response in patients with rectal cancer undergoing cetuximab-based neoadjuvant chemoradiation?. Onkologie 2009; 32: pp. 86-93.</p><li><p>41. Wieder H.A., Rosenberg R., Lordick F., et. al.: Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival. Radiology 2007; 243: pp. 744-751.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-18/'>Volume 18</a>, <a href='/categories/issue-11/'>Issue 11</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Spectral%20Presaturation%20Inversion%20Recovery%20MR%20Imaging%20Sequence%20after%20Gadolinium%20Injection%20to%20Differentiate%20Fibrotic%20Scar%20Tissue%20and%20Neoplastic%20Strands%20in%20the%20Mesorectal%20Fat%20in%20Patients%20Undergoing%20Restaging%20of%20Rectal%20Carcinoma%20after%20Neoadjuvant%20Chemo-%20and%20Radiation%20Therapy%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fspectral-presaturation-inversion-recovery-mr-imaging-sequence-after-gadolinium-injection-to-differen%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Spectral%20Presaturation%20Inversion%20Recovery%20MR%20Imaging%20Sequence%20after%20Gadolinium%20Injection%20to%20Differentiate%20Fibrotic%20Scar%20Tissue%20and%20Neoplastic%20Strands%20in%20the%20Mesorectal%20Fat%20in%20Patients%20Undergoing%20Restaging%20of%20Rectal%20Carcinoma%20after%20Neoadjuvant%20Chemo-%20and%20Radiation%20Therapy%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fspectral-presaturation-inversion-recovery-mr-imaging-sequence-after-gadolinium-injection-to-differen%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fspectral-presaturation-inversion-recovery-mr-imaging-sequence-after-gadolinium-injection-to-differen%2F&text=Spectral%20Presaturation%20Inversion%20Recovery%20MR%20Imaging%20Sequence%20after%20Gadolinium%20Injection%20to%20Differentiate%20Fibrotic%20Scar%20Tissue%20and%20Neoplastic%20Strands%20in%20the%20Mesorectal%20Fat%20in%20Patients%20Undergoing%20Restaging%20of%20Rectal%20Carcinoma%20after%20Neoadjuvant%20Chemo-%20and%20Radiation%20Therapy%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/an-observer-study-for-a-computer-aided-reading-protocol-carp-in-the-screening-environment-for-digi/"><div class="card-body"> <em class="small" data-ts="1320080400" data-df="ll" > Oct 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>An Observer Study for a Computer-Aided Reading Protocol (CARP) in the Screening Environment for Digital Mammography</h3><div class="text-muted small"><p> Rationale and Objectives The aims of this study were to investigate improving work flow efficiency by shortening the reading time of digital mammograms using a computer-aided reading protocol (CAR...</p></div></div></a></div><div class="card"> <a href="/posts/atlas-of-fetal-and-postnatal-brain-mr/"><div class="card-body"> <em class="small" data-ts="1320080400" data-df="ll" > Oct 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Atlas of Fetal and Postnatal Brain MR</h3><div class="text-muted small"><p> Imaging of the fetus, neonatal, and infant brains with magnetic resonance (MR) is increasingly common, particularly outside the confines of the larger pediatric referral centers. A large percentage...</p></div></div></a></div><div class="card"> <a href="/posts/case-based-interventional-neuroradiology/"><div class="card-body"> <em class="small" data-ts="1320080400" data-df="ll" > Oct 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Case-based Interventional Neuroradiology</h3><div class="text-muted small"><p> With this text, Krings and colleagues have attempted to take a subspecialty-level textbook and pare it down to the essentials using a case-based format. Gone are the introductory chapters describin...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/saving-manuscripts/" class="btn btn-outline-primary" prompt="Older"><p>Saving Manuscripts</p></a> <a href="/posts/verification-bias/" class="btn btn-outline-primary" prompt="Newer"><p>Verification Bias</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
